Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01440023 · ClinicalTrials.gov registry record · Phase 1
Developing Cognitive Training for Tourette Syndrome
A Phase 1 study of Tourette Syndrome and Chronic Tic Disorders, sponsored by University of Wisconsin, Milwaukee.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01440023: Completed Phase 1 study of Tourette Syndrome and Chronic Tic Disorders, sponsored by University of Wisconsin, Milwaukee.
NCT01440023 is a Phase 1 study of Tourette Syndrome and Chronic Tic Disorders that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 20 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01440023, a Phase 1 study of Tourette Syndrome and Chronic Tic Disorders, has completed, sponsored by University of Wisconsin, Milwaukee.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Many researchers suspect that individuals with Tourette Syndrome (TS) may have a poor cognitive ability (i.e., response inhibition; RI) that is essential to inhibit inappropriate response such as vocal or motor tics. The investigators aim to test whether a well-established behavior therapy for TS can be improved by increasing the individual's RI capabilities. To this end, 20 children will be randomly assigned to behavior therapy with computer-based RI training or behavior therapy with placebo computer-based cognitive training. The investigators will test the hypothesis that computer-based RI training can be a useful addition to the well-established behavior therapy to enhance its therapeutic effect.
Primary Outcome
The YGTSS is a well-validated instrument that produces severity ratings for motor and vocal tics, impairment caused by the tics, and an overall severity score of tic symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Comprehensive Behavioral Intervention for Tics (CBIT)
- BEHAVIORAL Computerized Response Inhibition Training
- BEHAVIORAL Computerized Placebo Cognitive Training
Study Locations (1)
Wisconsin
- The Psychology Clinic, University of Wisconsin-Milwaukee - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-12 |
| Phase | Phase 1 |
What the finished NCT01440023 record still lists
NCT01440023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Comprehensive Behavioral Intervention for Tics (CBIT) is the first listed.
NCT01440023 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01440023 about?
NCT01440023 is a clinical study titled "Developing Cognitive Training for Tourette Syndrome". Many researchers suspect that individuals with Tourette Syndrome (TS) may have a poor cognitive ability (i.e., response inhibition; RI) that is essential to inhibit inappropriate response such as vocal or motor tics. The investigators aim to test whether a well-established behavior therapy for TS ca...
What is the current status of trial NCT01440023?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-08. Estimated completion is 2014-12.
What conditions does trial NCT01440023 study?
This clinical trial studies the following conditions: Tourette Syndrome, Chronic Tic Disorders.
What interventions are being tested in trial NCT01440023?
The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (CBIT) (BEHAVIORAL), Computerized Response Inhibition Training (BEHAVIORAL), Computerized Placebo Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01440023?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01440023 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01440023's enrollment target sits among peer trials
20 27th of 33 higher than 5 of 33 other Tourette Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Open-Trial of EPI-743 for Adults With Tourette Syndrome
COMPLETED · Phase 1
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Sensory Symptoms in Tourette Syndrome
RECRUITING
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia